These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2908935)

  • 1. Papaverine-induced fibrosis of the corpus cavernosum.
    Fuchs ME; Brawer MK
    J Urol; 1989 Jan; 141(1):125. PubMed ID: 2908935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of fibrotic penile lesions secondary to the intracorporeal injection of vasoactive agents.
    Corriere JN; Fishman IJ; Benson GS; Carlton CE
    J Urol; 1988 Sep; 140(3):615-7. PubMed ID: 3411687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penile corporeal fibrosis complicating papaverine self-injection therapy for erectile impotence.
    Desai KM; Gingell JC
    Eur Urol; 1988; 15(1-2):132-3. PubMed ID: 3215228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.
    Larsen EH; Gasser TC; Bruskewitz RC
    J Urol; 1987 Feb; 137(2):292-3. PubMed ID: 3806824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of erectile dysfunction using papaverine--2 1/2 years' experience].
    Schnyder von Wartensee M; Sieber A; Studer UE
    Schweiz Med Wochenschr; 1988 Jul; 118(30):1099-103. PubMed ID: 3175561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of erectile dysfunction with corpus cavernosum autoinjection and current legal aspects].
    Werner W; Schubert J
    Z Arztl Fortbild (Jena); 1993 Feb; 87(2):165-8. PubMed ID: 8438604
    [No Abstract]   [Full Text] [Related]  

  • 13. Peyronie's-like plaque after penile injection of prostaglandin E1.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results and acceptance of corpus cavernosum autoinjection therapy in organic erectile dysfunction].
    Steffens J; Postma HJ; Steffens L
    Urologe A; 1988 Jan; 27(1):14-6. PubMed ID: 3363768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of persistent penile erection and priapism using terbutaline.
    Shantha TR; Finnerty DP; Rodriquez AP
    J Urol; 1989 Jun; 141(6):1427-9. PubMed ID: 2724442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracavernous injection therapy: analysis of results and complications.
    Lakin MM; Montague DK; VanderBrug Medendorp S; Tesar L; Schover LR
    J Urol; 1990 Jun; 143(6):1138-41. PubMed ID: 2342174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracavernous papaverine for impotence in spinal cord injured patients.
    Kapoor VK; Chahal AS; Jyoti SP; Mundkur YJ; Kotwal SV; Mehta VK
    Paraplegia; 1993 Oct; 31(10):675-7. PubMed ID: 8259331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracavernous injection of papaverine as a diagnostic procedure in patients with erectile dysfunction.
    Mouritsen L; Lyngdorf P; Frimodt-Møller C
    Scand J Urol Nephrol; 1988; 22(3):161-3. PubMed ID: 3187436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.